Equity Research

Scorecard
Library

Institutional-quality equity scorecards. Updated on demand. Each scorecard answers three questions: is the business strong, is the stock attractive at the current price, and what evidence over the next quarter confirms or weakens the thesis.

5
Active scorecards
2
Selective Buy
3
Hold / Watchlist
Apr 20
Last updated
19 scorecards
Active Positions
AVGO
Broadcom Inc. · NASDAQ
$350.63
+16.66%
73 /100
Selective Buy
Add on weakness. Google + Anthropic deal validates custom XPU moat. Entry discipline at $305–310.
Valuation
58
Fin. Health
82
Growth
80
Fwd P/E 23.2x
AI Rev YoY +106%
FCF Mgn 41.6%
Q2 Guide $22B
Updated Apr 08, 2026 Next: Jun 2026
MSFT
Microsoft Corporation · NASDAQ
$381.20
+2.40%
74 /100
Selective Buy
Add on weakness. 3-year valuation low. CapEx concern is solvable. Key trigger: Azure Q3 on Apr 28.
Valuation
65
Fin. Health
83
Growth
73
Fwd P/E 21.3x
Azure YoY +39%
FCF Mgn 38.8%
52W Pos. 13.9%
Updated Apr 08, 2026 Next: Apr 28, 2026
GOOGL
Alphabet Inc. Class A · NASDAQ
$317.32
+3.88%
71 /100
Hold / Don't Chase
Hold existing 105sh. At fair value, not cheap. Antitrust binary. Better entry at $270–285.
Valuation
62
Fin. Health
79
Growth
72
Fwd P/E 25.6x
Cloud YoY +48%
Cloud OM 30.1%
52W Pos. 84.6%
Updated Apr 08, 2026 Next: Apr 23, 2026
NTRA
Natera, Inc. · NASDAQ · Healthcare
$208.40
+6.27%
64 /100
Watchlist / Add on Weakness
Wait for $175–185. MRD platform dominant but class action + 12.9x EV/Rev limit upside at current price.
Valuation
49
Fin. Health
63
Growth
83
Rev Growth+36%
Gross Margin66.9%
EV/Rev 26E12.9x
MRD Vol Q4+56%
Updated Apr 20, 2026 Next: May 7, 2026
AMZN
Amazon.com, Inc. · NASDAQ · Cloud/Retail/Ads
$250.56
+0.34%
68 /100
Hold / Add on Pullback
Aspetta $210–220. Business eccellente ma PE 34x vicino ai massimi storici. Capex $200B comprime FCF fino al 2027.
Valuation
46
Fin. Health
74
Growth
87
AWS YoY+24%
AWS Backlog$244B
PE Trailing34x
52W Pos.92%
Updated Apr 20, 2026 Next: Apr 29, 2026
NVDA
NVIDIA Corporation · NASDAQ · Semiconductors
$202.06
+96% 52W
77/100
Selective Buy
Add ≤$195. Forward PE 24x, ROIC 126%, FCF $97B. Supply backlog $95B. AI infra dominance intatta.
Valuation
63
Fin. Health
91
Growth
77
Rev FY26$216B
FCF$97B
Fwd PE24x
ROIC126%
Updated Apr 21, 2026 Next: May 27, 2026
SU.PA
Schneider Electric S.E. · EPA · Energy Tech
€275
+30% 52W
78/100
Selective Buy
Add at current levels. Best AI infra pick-and-shovel in Europe. Backlog +18%, FCF conversion 111%, ROCE >15%.
Valuation
69
Fin. Health
74
Growth
93
Organic+9%
Backlog€25.4B
Fwd PE27x
FCF Conv.111%
Updated Apr 21, 2026 Next: Apr 30, 2026
ANET
Arista Networks · NYSE · AI Networking
$172
+159% 52W
78/100
Hold / Add on Pullback
Entry ideale ≤$150. EOS moat, op margin 48%, ROIC 176%. A $172 fwd PE ~39x — valutazione tesa.
Valuation
51
Fin. Health
94
Growth
90
Rev 2025$9.0B
Op Margin48.2%
Fwd PE~39x
ROIC176%
Updated Apr 21, 2026 Next: May 5, 2026
ENEL
Enel S.p.A. · BIT · Utility / Rinnovabili
€9.72
+34% 52W
72/100
Buy / Income + Transition
Add at current levels. Fwd PE 13x, yield ~4.8%, beta 0.76. Maggiore utility europea per EBITDA.
Valuation
77
Fin. Health
63
Growth
77
EBITDA€22.9B
Yield~4.8%
Fwd PE~13x
Beta0.76
Updated Apr 21, 2026 Next: May 7, 2026
ECL
Ecolab Inc. · NYSE · Water / Hygiene
$268.86
+4% 52W
70/100
Hold / Add on Weakness
Entry ideale ≤$245. Quality compounder con moat idrico. Fwd PE 31x — non cheap ma solido compounder +13% EPS.
Valuation
54
Fin. Health
71
Growth
87
Rev FY25$16.1B
Adj EPS$7.53
Fwd PE31x
EPS guide+12–15%
Updated Apr 22, 2026 Next: Apr 28, 2026
AKRBP
Aker BP ASA · Oslo Børs · Oil & Gas NCS
kr 333
+55% 52W
70/100
Buy / High Conviction Bet
Tesi sul 2028. OCF record $7B. Yield ~7.4% +5%/yr. Beta -0.09. 525K boepd target. Richiede pazienza e petrolio >$65.
Valuation
74
Fin. Health
63
Growth
73
OCF FY25$7.0B
Yield~7.4%
P/E norm~11x
Beta-0.09
Updated Apr 23, 2026 Next: May 7, 2026
TMDX
TransMedics Group · NASDAQ · MedTech
$114
-27% dal high
76/100
High Conviction Bet
36% US liver transplants via OCS. Market creation, not share. Rev +37% FY25. Target 30% margin 2028. Scommessa ad alta asimmetria.
Valuation
66
Fin. Health
69
Growth
97
Rev FY25$605M
Growth+37%
2026 guide+20-25%
Analyst PT$148
Updated Apr 23, 2026 Next: May 2026
ABB
ABB Ltd · SIX:ABBN · Electrification
CHF 78
+86% 52W · ATH
76/100
Hold / Add ≤CHF 62
Business record in ogni metrica. ROCE 25%, FCF $4.6B, ordini Q1 +24%. Problema: sopra consensus PT. Add solo su pullback -20%+.
Valuation
54
Fin. Health
89
Growth
87
FCF FY25$4.6B
ROCE25.3%
Fwd PE27x
vs PT cons.+20%↑
Updated Apr 23, 2026 Next: Jul 17, 2026
NOW
ServiceNow · NYSE · Enterprise AI Platform
$85
-17% oggi 📉
81/100
Post-Dip Entry Window
Q1 beat, guidance raised. -17% da margin headwinds Armis + geopolitica. Business intatto. Fwd PE 24x, cRPO +22.5%, FCF 44%. Finestra rara.
Valuation
77
Fin. Health
80
Growth
87
cRPO$12.64B
Sub Rev 26E$15.75B
Fwd PE~24x
FCF Q144%
Updated Apr 23, 2026 Next: Jul 21, 2026
LIN
Linde plc · NASDAQ · Industrial Gases
$492
Near ATH
78/100
Hold / Add ≤$440
Quality compounder assoluto. EBITDA margin 38%, ROC 24%, $7.4B restituiti 2025. Ingrediente invisibile di tutto. Add on pullback -10%.
Valuation
63
Fin. Health
97
Growth
73
Adj. EPS$16.46
OCF$10.4B
EBITDA38.3%
Fwd PE27x
Updated Apr 23, 2026 Next: May 1, 2026
UAL
United Airlines · NASDAQ · Airlines
$93
+74% 52W low
70/100
Speculative / Macro Bet
Q1 beat, business solido. FY26 EPS \$7-11 (Iran fuel). PE 8.5x. Upside 40%+ se ceasefire. Scommessa macro pura sul petrolio.
Valuation
83
Fin. Health
57
Growth
70
Q1 Rev$14.6B
TTM P/E8.5x
FY26 EPS$7–$11
ROE25.7%
Updated Apr 23, 2026 Next: Jul 14, 2026
ASML
ASML Holding N.V. · AMS · EUV Monopoly
€1,245
+122% 52W
82/100
Hold / Add ≤€1,050
Monopolio EUV 100%. Zero competitor. Q1 €8.8B beat. Guidance raised €36-40B. Backlog €38.8B. Add su pullback -15%+.
Valuation
63
Fin. Health
97
Growth
87
Backlog€38.8B
ROE50.5%
Fwd PE~34x
GM Q153.0%
Updated Apr 23, 2026 Next: Jul 16, 2026
CRWD
CrowdStrike · NASDAQ · Cybersecurity AI
$448
+31% 52W
81/100
Selective Buy / Add ≤$410
ARR $5.25B +24%, net new ARR Q4 RECORD +47%. Outage completamente assorbita. Falcon Flex +120%. FY27 guida $5.9B.
Valuation
63
Fin. Health
83
Growth
100
ARR$5.25B
Flex ARR$1.69B
FY27 Rev$5.9B
GM76.1%
Updated Apr 25, 2026 Next: Jun 2, 2026
ISRG
Intuitive Surgical · NASDAQ · Robotic Surgery
$482
+7.9% post-Q1
83/100
Hold / Add ≤$445
Q1 flawless. Proc +17%, Rev +23%, EPS beat +$0.39. 11,395 sistemi. da Vinci 5 54% di nuovi placements. Add su pullback.
Valuation
63
Fin. Health
94
Growth
93
Rev Q1$2.77B
Proc.+17%
Installed11,395
Recurring86%
Updated Apr 25, 2026 Next: Jul 2026
Add next scorecard ISRG · ANET · ASML · RACE · CSU.TO…